Abstract: An annular seal for sealing an opening in a pump housing surrounding a piston rod includes a primary sealing portion with an inner surface adjacent to the piston rod and an outer surface adjacent to the pump housing. An initial sealing portion features an inner wall and an outer wall so that an annular space is defined therebetween. A top wall extends between the inner and outer walls. A coil spring is positioned within the annular space of the initial sealing portion and urges the inner wall into engagement with the piston rod and the outer wall into engagement with the pump housing.

Abstract: An annular seal for sealing an opening in a pump housing surrounding a piston rod includes a primary sealing portion with an inner surface adjacent to the piston rod and an outer surface adjacent to the pump housing. An initial sealing portion features an inner wall and an outer wall so that an annular space is defined therebetween. A top wall extends between the inner and outer walls. A coil spring is positioned within the annular space of the initial sealing portion and urges the inner wall into engagement with the piston rod and the outer wall into engagement with the pump housing.

Abstract: A system for dispensing a cryogenic fluid includes a bulk tank configured to contain a supply of a cryogenic liquid, a first sump and a first liquid feed valve configured to direct liquid from the bulk tank to the first sump when in an open condition and to prevent transfer of liquid from the bulk tank to the first sump when in a closed condition. A first positive displacement pump is positioned within the first sump and configured to pump and be submerged in cryogenic liquid when the first sump contains cryogenic liquid above a predetermined liquid level within the first sump. A delivery line is in fluid communication with an outlet of the first positive displacement pump and is configured to direct cryogenic fluid from the first positive displacement pump to a use device when the first positive displacement pump is activated.

Abstract: A system for dispensing a cryogenic fluid includes a bulk storage tank configured to contain a supply of the cryogenic fluid. A heat exchanger coil is positioned in the headspace of at least one intermediate fluid tank, which contains an intermediate fluid, and is configured to receive and warm a cryogenic fluid from the bulk storage tank via heat exchange with intermediate fluid vapor in the headspace. A buffer tank receives fluid from the heat exchanger coil. A chiller coil is positioned within the intermediate fluid tank and is submerged within intermediate fluid liquid contained within the at least one intermediate fluid tank. The chiller coil receives fluid from the buffer tank and cools it via heat exchange with intermediate fluid liquid within which the chiller coil is submerged for dispensing.

Abstract: A system for dispensing a cryogenic fluid includes a bulk storage tank configured to contain a supply of the cryogenic fluid. A heat exchanger coil is positioned in the headspace of at least one intermediate fluid tank, which contains an intermediate fluid, and is configured to receive and warm a cryogenic fluid from the bulk storage tank via heat exchange with intermediate fluid vapor in the headspace. A buffer tank receives fluid from the heat exchanger coil. A chiller coil is positioned within the intermediate fluid tank and is submerged within intermediate fluid liquid contained within the at least one intermediate fluid tank. The chiller coil receives fluid from the buffer tank and cools it via heat exchange with intermediate fluid liquid within which the chiller coil is submerged for dispensing.

Abstract: The present invention generally relates to the transdermal delivery of substances and, in some embodiments, to the transdermal delivery of beneficial substances by a hostile biophysical environment. In one aspect, various methods for the transdermal delivery of beneficial substances are disclosed. By creating a hostile biophysical environment, beneficial substances may be delivered, according to certain embodiments, through the stratum corneum of the skin into the body. Beneficial substances include, but are not limited to, pharmaceutical agents, drugs, vitamins, co-factors, peptides, dietary supplements, and others. The beneficial effects disclosed include, for instance, relief of pain and inflammation, prevention and healing of ulcers of the skin, relief of headache, improved sexual function and enjoyment, growth of hair on the scalp, improving muscle size and/or function, removing body fat and/or cellulite, treating cancer, treating viral infections and others.

Abstract: The present invention generally relates to the transdermal delivery of substances In one aspect, various methods for the transdermal delivery of beneficial substances are disclosed. By creating a hostile biophysical environment, beneficial substances may be delivered, according to certain embodiments, through the stratum corneum of the skin into the body. Beneficial substances include, but are not limited to, pharmaceutical agents, drugs, vitamins, co-factors, peptides, dietary supplements, and others. The beneficial effects disclosed include, for instance, relief of pain and inflammation, prevention and healing of ulcers of the skin, relief of headache, improved sexual function and enjoyment, growth of hair on the scalp, improving muscle size and/or function, removing body fat and/or cellulite, treating cancer, treating viral infections and others. A hostile biophysical environment may also be used in conjunction with systems and methods for increasing local blood flow, according to one set of embodiments.

Abstract: The present invention generally relates to the improvement of tissue health by increasing local blood flow. In some aspects of the invention, increased local blood flow is effected by the transdermal delivery of the nitric oxide precursor L-arginine and/or its derivatives alone, or optionally in conjunction with an adjunct such as theophylline. The transdermal delivery is effected, in certain embodiments through the means of a hostile biophysical environment, such as that created by a high ionic strength environment. Various pathological states caused by, or occurring in conjunction with, insufficient blood flow, can be treated using the systems and methods of the invention as described herein. In other embodiments, increased blood flow using the systems and methods of the invention may result in enhanced healing, for example, through greater availability of the constituents of the blood.

Abstract: The present invention generally relates to the transdermal delivery of substances and, in some embodiments, to the transdermal delivery of beneficial substances by a hostile biophysical environment. In one aspect, various methods for the transdermal delivery of beneficial substances are disclosed. By creating a hostile biophysical environment, beneficial substances may be delivered, according to certain embodiments, through the stratum corneum of the skin into the body. Beneficial substances include, but are not limited to, pharmaceutical agents, drugs, vitamins, co-factors, peptides, dietary supplements, and others. The beneficial effects disclosed include, for instance, relief of pain and inflammation, prevention and healing of ulcers of the skin, relief of headache, improved sexual function and enjoyment, growth of hair on the scalp, improving muscle size and/or function, removing body fat and/or cellulite, treating cancer, treating viral infections and others.

Abstract: This invention generally relates to improvement of the body and skin appearance, for example enhancing the appearance of sagging, wrinkled, or cellulite-afflicted areas of the skin and body, through the local delivery of a nitric oxide donor, for example, using delivery vehicles such as lotions, creams, liquids, and/or transdermal patches. In some embodiments, a delivery vehicle containing a nitric oxide donor, for example, L-arginine (an important biological precursor) or its derivatives in a sufficient concentration to improve the appearance of a selected area of the body may be applied. In certain cases, one or more agents may also be included that aid in the transfer of the nitric oxide donor into the tissue, which may overcome the resistance to transfer into the skin. Non-limiting examples of suitable agents include agents able to create hostile biophysical environments, for instance, choline chloride, magnesium chloride, and/or sodium chloride.

Abstract: The present invention generally relates to the transdermal delivery of substances and, in some embodiments, to the transdermal delivery of beneficial substances by a hostile biophysical environment. In one aspect, various methods for the transdermal delivery of beneficial substances are disclosed. By creating a hostile biophysical environment, beneficial substances may be delivered, according to certain embodiments, through the stratum corneum of the skin into the body. Beneficial substances include, but are not limited to, pharmaceutical agents, drugs, vitamins, co-factors, peptides, dietary supplements, and others. The beneficial effects disclosed include, for instance, relief of pain and inflammation, prevention and healing of ulcers of the skin, relief of headache, improved sexual function and enjoyment, growth of hair on the scalp, improving muscle size and/or function, removing body fat and/or cellulite, treating cancer, treating viral infections and others.

Abstract: The present invention generally relates to the transdermal delivery of substances and, in some embodiments, to the transdermal delivery of beneficial substances by a hostile biophysical environment. In one aspect, various methods for the transdermal delivery of beneficial substances are disclosed. By creating a hostile biophysical environment, beneficial substances may be delivered, according to certain embodiments, through the stratum corneum of the skin into the body. Beneficial substances include, but are not limited to, pharmaceutical agents, drugs, vitamins, co-factors, peptides, dietary supplements, and others. The beneficial effects disclosed include, for instance, relief of pain and inflammation, prevention and healing of ulcers of the skin, relief of headache, improved sexual function and enjoyment, growth of hair on the scalp, improving muscle size and/or function, removing body fat and/or cellulite, treating cancer, treating viral infections and others.

Abstract: The present invention provides a treatment for enhancing the ability of the body to heal wounds. A topical cream is described which improves blood flow by the transdermal delivery of the nitric oxide precursor L-Arginine either alone or with an adjunct, theophylline. The delivery of the active agents is accomplished by use of a vehicle which contains a hostile biophysical environment which is also hostile to hydrogen bond formation.

Abstract: The present invention generally relates to the transdermal delivery of substances and, in some embodiments, to the transdermal delivery of beneficial substances by a hostile biophysical environment. In one aspect, various methods for the transdermal delivery of beneficial substances are disclosed. By creating a hostile biophysical environment, beneficial substances may be delivered, according to certain embodiments, through the stratum corneum of the skin into the body. Beneficial substances include, but are not limited to, pharmaceutical agents, drugs, vitamins, co-factors, peptides, dietary supplements, and others. The beneficial effects disclosed include, for instance, relief of pain and inflammation, prevention and healing of ulcers of the skin, relief of headache, improved sexual function and enjoyment, growth of hair on the scalp, improving muscle size and/or function, removing body fat and/or cellulite, treating cancer, treating viral infections and others.

Abstract: This invention generally relates to improvement of the body and skin appearance, for example enhancing the appearance of sagging, wrinkled, or cellulite-afflicted areas of the skin and body, through the local delivery of a nitric oxide donor, for example, using delivery vehicles such as lotions, creams, liquids, and/or transdermal patches. In some embodiments, a delivery vehicle containing a nitric oxide donor, for example, L-arginine (an important biological precursor) or its derivatives in a sufficient concentration to improve the appearance of a selected area of the body may be applied. In certain cases, one or more agents may also be included that aid in the transfer of the nitric oxide donor into the tissue, which may overcome the resistance to transfer into the skin. Non-limiting examples of suitable agents include agents able to create hostile biophysical environments, for instance, choline chloride, magnesium chloride, and/or sodium chloride.

Abstract: A storable gas inflation/evacuation system and sealing system. The systems are removably connectible to a proximal portion of a guidewire assembly which has an occlusive balloon at a distal portion. The invention includes provision for indicating the presence of oxygen which is undesirable. The storable aspect concerns a sealable container isolating systems components from ambient atmosphere and an oxygen-sensitive material located within the sealable container. The oxygen-sensitive material is initially inactive but activated by exposure to radiation so as to visually change in response to post-radiation oxygen exposure.

Abstract: A pneumatically-operated thrombectomy catheter deployment system having a plurality of components collectively acting as a drive unit, including a double-acting air cylinder, a reciprocating assembly including a positionable four-way valve, a high pressure pump, an effluent pump, a compressed air tank, and other closely related components. The double-acting air cylinder is reciprocatingly driven by the complement of the drive unit components to provide high pressure saline for use in the thrombectomy catheter and to exhaust effluent from the system. A plurality of preconnected components are connected to the drive unit including a thrombectomy catheter, a saline supply bag, an effluent collection bag, connection tubes, and other closely related components.

Abstract: A method and system for use in the course of extracorporeal blood flow, e.g., cardiopulmonary bypass, dialysis, and angioplasty procedures, in order to reduce or minimize inflammation, excessive bleeding, and other undesirable side effects. The system can include one or more automated blood parameter sensor modules and one or more blood parameter regulating modules. The system is particularly well suited to monitor and/or regulate blood parameters that include blood analytes (e.g., biomolecules, drugs or metabolites) as well as blood functions (e.g., clotting time, fibrinolytic activity, immune response). The system is particularly well suited for use in the management of clotting (e.g., heparin/protamine) and bleeding (e.g., aprotinin).

Abstract: A thrombectomy catheter deployment system which greatly simplifies setup procedures and operation of a thrombectomy catheter includes a stand alone drive unit and a disposable pump/catheter assembly which is manually placed into a carriage assembly in the drive unit. The pump/catheter assembly has a plurality of preconnected components including tubular structure and a thrombectomy catheter connected thereto and is transported into or out of the interior of the drive unit for automatic high pressure pump piston head engagement or disengagement with a reciprocating linear actuator and for automatic engagement or disengagement of an effluent waste tube with a roller pump. A barcode reader senses specific operational data pertaining to an individual pump and provides an interface for operation of the reciprocating linear actuator. A bubble trap incorporated for effective debubbling of saline solution is closely coupled to an insert molded pump having an improved valve arrangement.

Abstract: An occlusive guidewire system having an ergonomic handheld control mechanism and torqueable kink-resistant guidewire having a distally located inflatable balloon. The present invention provides convenient structure and overall mechanism for operation of a torqueable kink-resistant guidewire, including evacuation and inflation control of an occlusive balloon, and sealing and severing of a crimpable inflation tube which is in communication with an occlusive balloon. The torqueable kink-resistant guidewire includes a centrally located shaft which imparts robustness to the torqueable kink-resistant guidewire. An inflation lumen aligns within the torqueable kink-resistant guidewire for inflation of the balloon.